Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/3O8 stock hub

FRA/3O8 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/3O8is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

864.3M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/3O8FRA/3O8

—

Loading chart…

In the news

Latest news · FRA/3O8

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E27.9

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-41.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/3O8 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

145

Groups with data

Currency

USD

Showing 145 of 145 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	175
Employees Change	4%
Employees Change Percent	2.02
Enterprise value	EUR 930.6M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 864.3M
Price	EUR 12.2
Price currency	EUR
Sic	2836
Symbol	fra/3O8
Website	https://www.omeros.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.33%
EV Earnings	-326.16x
EV/FCF	-9.41x
FCF yield	-11.45%
Forward P/E	27.89x
P/B ratio	-8.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -30.3M
Net Income	EUR -2.9M
Profit Per Employee	EUR -16,304
ROA	-25.47
Roa5y	-26.98
ROCE	-49.6
ROIC	-41.54

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.3%
Cagr15y	9.22%
Cagr1y	119.54%
Cagr3y	38.25%
Cagr5y	-3.37%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 277.3M
Cash	EUR 146.3M
Current Assets	EUR 182.9M
Current Liabilities	EUR 66.2M
Debt	EUR 212.8M
Debt FCF	EUR -2.15
Equity	EUR -103.3M
Interest Coverage	-9.23
Liabilities	EUR 380.6M
Long Term Assets	EUR 94.5M
Long Term Liabilities	EUR 314.4M
Net Cash	EUR -66.5M
Net Cash By Market Cap	EUR -7.69
Tangible Book Value	EUR -103.3M
Tangible Book Value Per Share	EUR -1.44

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.76
Net Working Capital	EUR 8.3M
Quick ratio	2.34
Working Capital	EUR 117.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.18%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	13.73%
1Y total return	119.42%
200-day SMA	7.58
3Y total return	164.3%
50-day SMA	10.26
50-day SMA vs 200-day SMA	50over200
5Y total return	-15.75%
All Time High	25.48
All Time High Change	-52.11%
All Time High Date	2015-08-18
All Time Low	0.98
All Time Low Change	1,148.72%
All Time Low Date	2023-10-27
ATR	0.29
Ch YTD	-9.63
High	12.2
High52	15.46
High52 Date	2026-01-02
High52ch	-21.09%
Low	12.2
Low52	2.49
Low52 Date	2025-07-02
Low52ch	390.75%
Ma50ch	18.87%
Price vs 200-day SMA	60.99%
RSI	64.01
RSI Monthly	62.02
RSI Weekly	66.08
Sharpe ratio	1.02x
Sortino ratio	3.24
Total Return	-9.18%
Tr YTD	-9.63
Tr15y	275.39%
Tr1m	31.47%
Tr1w	-3.17%
Tr3m	29.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -104.6M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	69,421,908%
Net Borrowing	-57,513,870.6
Shares Insiders	3.58%
Shares Institutions	47.17%
Shares Qo Q	33.52%
Shares Yo Y	9.18%
Short Ratio	16.6

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -105.9M
Average Volume	4.25x
Bv Per Share	-1.44
CAPEX	EUR -55,361
Ch10y	13.73
Ch15y	275.4
Ch1m	31.47
Ch1w	-3.17
Ch1y	119.4
Ch3m	29.17
Ch3y	164.3
Ch5y	-15.75
Ch6m	116.9
Change	-2.4%
Change From Open	0
Close	12.5
Days Gap	-2.4
Depreciation Amortization	817,435.4
Earnings Date	2026-05-14
EBIT	EUR -104.6M
EBITDA	EUR -103.8M
EPS	EUR -0.04
F Score	2
FCF	EUR -98.9M
FCF EV Yield	-10.63x
Financing CF	-35,915,337
Fiscal Year End	December
Founded	1,994
Income Tax	EUR 1.7M
Investing CF	140,124,239
Is Primary Listing	0
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Ma150	8.93
Ma150ch	36.57%
Ma20	11.38
Ma20ch	7.22%
Net CF	5,331,642
Next Earnings Date	2026-05-14
Open	12.2
Ppne	10,579,173.9
Price Date	2026-05-08
Relative Volume	14.12x
Share Based Comp	6,977,126
Tr6m	116.89%
Volume	0

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/3O8 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/3O8 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/3O8?

Insider, institutional, and short-interest positioning.

Institutional ownership

+47.2%

Share of float held by funds and institutions

Insider ownership

+3.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/3O8 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.0

Neutral momentum band

Price vs 200-day MA

+61.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/3O8

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/3O8 stock rating?

fra/3O8 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/3O8 analysis?

The full report lives at /stocks/fra/3O8/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/3O8?

The latest report frames fra/3O8 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/3O8 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.